Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome Intervention: Other: Bifidobacterium longum 35624 Sponsors: Medice Arzneimittel Pütter GmbH & Co KG; BioTeSys GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Irritable Bowel Syndrome | Research